{"transactions":[{"id":680369,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-20T20:37:16.000Z","date":"2026-08-19","kind":"gift","planned":false,"acquired":false,"shares":528,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":35485,"source":{"system":"sec-edgar","filing":"0001100682-26-000138","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000138/form4.xml","form_type":"4"}},{"id":688274,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-08-13T20:37:36.000Z","date":"2026-08-11","kind":"exercise","planned":true,"acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":179.66,"exercise_date":"2021-05-29","expiration_date":"2030-05-29","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001100682-26-000132","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000132/form4.xml","form_type":"4"}},{"id":688273,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-13T20:37:36.000Z","date":"2026-08-11","kind":"sale","planned":true,"acquired":false,"shares":6500,"price":279.9,"value":1819350.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 3, 2025."}],"balance_after":36013,"source":{"system":"sec-edgar","filing":"0001100682-26-000132","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000132/form4.xml","form_type":"4"}},{"id":688272,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-13T20:37:36.000Z","date":"2026-08-11","kind":"exercise","planned":true,"acquired":true,"shares":6500,"price":179.66,"value":1167790.0,"ownership":{"direct":true},"balance_after":42513,"source":{"system":"sec-edgar","filing":"0001100682-26-000132","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000132/form4.xml","form_type":"4"}},{"id":746682,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-08T20:21:53.000Z","date":"2026-06-05","kind":"gift","planned":false,"acquired":true,"shares":3386,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Revocable Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the exempt transfer pursuant to Rule 16a-13 of 3,386 shares held by the reporting person to a revocable trust controlled by the reporting person."}],"balance_after":43803,"source":{"system":"sec-edgar","filing":"0001100682-26-000107","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000107/form4.xml","form_type":"4"}},{"id":746681,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-08T20:21:53.000Z","date":"2026-06-05","kind":"gift","planned":false,"acquired":false,"shares":3386,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the exempt transfer pursuant to Rule 16a-13 of 3,386 shares held by the reporting person to a revocable trust controlled by the reporting person."}],"balance_after":36013,"source":{"system":"sec-edgar","filing":"0001100682-26-000107","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000107/form4.xml","form_type":"4"}},{"id":755524,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-02T20:35:17.000Z","date":"2026-05-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":378,"price":180.71,"value":68308.38,"ownership":{"direct":true},"balance_after":39399,"source":{"system":"sec-edgar","filing":"0001100682-26-000093","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000093/form4.xml","form_type":"4"}},{"id":755523,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-02T20:35:17.000Z","date":"2026-05-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":1204,"price":180.71,"value":217574.84,"ownership":{"direct":true},"balance_after":39777,"source":{"system":"sec-edgar","filing":"0001100682-26-000093","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000093/form4.xml","form_type":"4"}},{"id":755522,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-02T20:35:17.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":9961,"price":180.71,"value":1800052.31,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Unvested restricted stock units annually ratably vest on: May 29, 2027; May 29, 2028; May 29, 2029; May 29, 2030."}],"balance_after":40981,"source":{"system":"sec-edgar","filing":"0001100682-26-000093","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000093/form4.xml","form_type":"4"}},{"id":760599,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-28T20:33:03.000Z","date":"2026-05-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":242,"price":156.73,"value":37928.66,"ownership":{"direct":true},"balance_after":31020,"source":{"system":"sec-edgar","filing":"0001100682-26-000079","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000079/form4.xml","form_type":"4"}},{"id":760598,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-28T20:33:03.000Z","date":"2026-05-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":376,"price":160.3,"value":60272.8,"ownership":{"direct":true},"balance_after":31262,"source":{"system":"sec-edgar","filing":"0001100682-26-000079","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000079/form4.xml","form_type":"4"}},{"id":859204,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2026-03-05T22:18:17.000Z","date":"2026-03-04","kind":"gift","planned":false,"acquired":false,"shares":328,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Revocable Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares that were previously reported as directly held, which are now correctly reported as indirectly held."}],"balance_after":40417,"source":{"system":"sec-edgar","filing":"0001100682-26-000028","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000028/form4.xml","form_type":"4"}},{"id":925622,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2026-02-02T21:42:36.000Z","date":"2026-01-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":3061,"price":211.68,"value":647952.48,"ownership":{"direct":true},"balance_after":26913,"source":{"system":"sec-edgar","filing":"0001100682-26-000010","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000010/form4.xml","form_type":"4"}},{"id":925621,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2026-02-02T21:42:36.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 26, 2023."}],"balance_after":29974,"source":{"system":"sec-edgar","filing":"0001100682-26-000010","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000010/form4.xml","form_type":"4"}},{"id":1125772,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2025-06-03T20:52:38.000Z","date":"2025-05-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":283,"price":135.63,"value":38383.29,"ownership":{"direct":true},"balance_after":65944,"source":{"system":"sec-edgar","filing":"0001127602-25-016544","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225016544/form4.xml","form_type":"4"}},{"id":1125771,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2025-06-03T20:52:38.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":12239,"price":135.63,"value":1659975.57,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Unvested restricted stock units vest annually on: May 30, 2026; May 30, 2027; May 30, 2028; May 30, 2029."}],"balance_after":66227,"source":{"system":"sec-edgar","filing":"0001127602-25-016544","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225016544/form4.xml","form_type":"4"}},{"id":1130903,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2025-05-29T20:58:03.000Z","date":"2025-05-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":117,"price":138.65,"value":16222.05,"ownership":{"direct":true},"balance_after":53988,"source":{"system":"sec-edgar","filing":"0001127602-25-015895","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225015895/form4.xml","form_type":"4"}},{"id":1130902,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2025-05-29T20:58:03.000Z","date":"2025-05-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":242,"price":136.73,"value":33088.66,"ownership":{"direct":true},"balance_after":54105,"source":{"system":"sec-edgar","filing":"0001127602-25-015895","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225015895/form4.xml","form_type":"4"}},{"id":1130901,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2025-05-29T20:58:03.000Z","date":"2025-05-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":281,"price":136.73,"value":38421.13,"ownership":{"direct":true},"balance_after":54347,"source":{"system":"sec-edgar","filing":"0001127602-25-015895","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225015895/form4.xml","form_type":"4"}},{"id":1243839,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2025-02-26T21:18:10.000Z","date":"2025-02-25","kind":"gift","planned":false,"acquired":false,"shares":430,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":54628,"source":{"system":"sec-edgar","filing":"0001127602-25-006850","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225006850/form4.xml","form_type":"4"}},{"id":1253677,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2025-02-21T21:38:37.000Z","date":"2025-02-20","kind":"purchase","planned":false,"acquired":true,"shares":1514,"price":164.63,"value":249249.82,"ownership":{"direct":true},"balance_after":55058,"source":{"system":"sec-edgar","filing":"0001127602-25-006251","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225006251/form4.xml","form_type":"4"}},{"id":1287745,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2025-02-03T21:22:40.000Z","date":"2025-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1025,"price":165.57,"value":169709.25,"ownership":{"direct":true},"balance_after":53544,"source":{"system":"sec-edgar","filing":"0001127602-25-002714","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225002714/form4.xml","form_type":"4"}},{"id":1287744,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2025-02-03T21:22:40.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":4057,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 27, 2022."}],"balance_after":54569,"source":{"system":"sec-edgar","filing":"0001127602-25-002714","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225002714/form4.xml","form_type":"4"}},{"id":1493135,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-06-04T20:21:22.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":8722,"price":208.44,"value":1818013.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Stock options vest as follows: 2,180 on May 31, 2025, 2,181 on May 31, 2026,  2,180 on May 31, 2027, and  2,181 on May 31, 2028."}],"balance_after":8722,"derivative":{"exercise_price":208.44,"exercise_date":"2025-05-31","expiration_date":"2034-05-31","underlying":"Common Stock","underlying_shares":8722},"source":{"system":"sec-edgar","filing":"0001127602-24-017674","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224017674/form4.xml","form_type":"4"}},{"id":1493134,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2024-06-04T20:21:22.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":3838,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Unvested restricted stock units vest as follows: 959 on May 31, 2025,  960 on May 31, 2026,  959 on May 31, 2027, and  960 on May 31, 2028."}],"balance_after":50512,"source":{"system":"sec-edgar","filing":"0001127602-24-017674","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224017674/form4.xml","form_type":"4"}},{"id":1499434,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2024-05-29T21:46:18.000Z","date":"2024-05-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":216,"price":214.51,"value":46334.16,"ownership":{"direct":true},"balance_after":46674,"source":{"system":"sec-edgar","filing":"0001127602-24-016818","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224016818/form4.xml","form_type":"4"}},{"id":1500827,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2024-05-28T21:25:57.000Z","date":"2024-05-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":132,"price":217.21,"value":28671.72,"ownership":{"direct":true},"balance_after":46890,"source":{"system":"sec-edgar","filing":"0001127602-24-016724","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224016724/form4.xml","form_type":"4"}},{"id":1500826,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2024-05-28T21:25:57.000Z","date":"2024-05-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":242,"price":217.21,"value":52564.82,"ownership":{"direct":true},"balance_after":47022,"source":{"system":"sec-edgar","filing":"0001127602-24-016724","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224016724/form4.xml","form_type":"4"}},{"id":1500825,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2024-05-28T21:25:57.000Z","date":"2024-05-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":376,"price":217.21,"value":81670.96,"ownership":{"direct":true},"balance_after":47264,"source":{"system":"sec-edgar","filing":"0001127602-24-016724","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224016724/form4.xml","form_type":"4"}},{"id":1562166,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2024-03-25T21:52:37.000Z","date":"2024-01-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":1135,"price":220.28,"value":250017.8,"ownership":{"direct":true},"balance_after":48064,"source":{"system":"sec-edgar","filing":"0001127602-24-011096","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224011096/form4a.xml","form_type":"4/A","original_submission_date":"2024-01-31"}},{"id":1562165,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2024-03-25T21:52:37.000Z","date":"2024-01-29","kind":"grant","planned":false,"acquired":true,"shares":3451,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 28, 2021."}],"balance_after":49199,"source":{"system":"sec-edgar","filing":"0001127602-24-011096","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224011096/form4a.xml","form_type":"4/A","original_submission_date":"2024-01-31"}},{"id":1638896,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2024-02-16T23:37:32.000Z","date":"2024-02-15","kind":"gift","planned":false,"acquired":false,"shares":424,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":47691,"source":{"system":"sec-edgar","filing":"0001127602-24-005439","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224005439/form4.xml","form_type":"4"}},{"id":1665548,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2024-02-01T00:14:00.000Z","date":"2024-01-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":1159,"price":220.28,"value":255304.52,"ownership":{"direct":true},"balance_after":48115,"source":{"system":"sec-edgar","filing":"0001127602-24-002840","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224002840/form4.xml","form_type":"4"}},{"id":1665547,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2024-02-01T00:14:00.000Z","date":"2024-01-29","kind":"grant","planned":false,"acquired":true,"shares":3526,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 28, 2021."}],"balance_after":49274,"source":{"system":"sec-edgar","filing":"0001127602-24-002840","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224002840/form4.xml","form_type":"4"}},{"id":1665546,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-01-31T22:34:45.000Z","date":"2024-01-10","kind":"exercise","planned":false,"acquired":false,"shares":5916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The transaction was executed as a net exercise, in which no shares were purchased or sold in the open market."}],"balance_after":0,"derivative":{"exercise_price":144.67,"exercise_date":"2020-02-22","expiration_date":"2024-02-22","underlying":"Common Stock","underlying_shares":5916},"source":{"system":"sec-edgar","filing":"0001127602-24-002811","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224002811/form4a.xml","form_type":"4/A","original_submission_date":"2024-01-11"}},{"id":1665545,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2024-01-31T22:34:45.000Z","date":"2024-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":4617,"price":213.14,"value":984067.38,"ownership":{"direct":true},"balance_after":45748,"source":{"system":"sec-edgar","filing":"0001127602-24-002811","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224002811/form4a.xml","form_type":"4/A","original_submission_date":"2024-01-11"}},{"id":1665544,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2024-01-31T22:34:45.000Z","date":"2024-01-10","kind":"exercise","planned":false,"acquired":true,"shares":5916,"price":144.67,"value":855867.72,"ownership":{"direct":true},"balance_after":50365,"source":{"system":"sec-edgar","filing":"0001127602-24-002811","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224002811/form4a.xml","form_type":"4/A","original_submission_date":"2024-01-11"}},{"id":1680956,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-01-11T21:09:52.000Z","date":"2024-01-10","kind":"exercise","planned":false,"acquired":false,"shares":5916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The transaction was executed as a net exercise, in which no shares were purchased or sold in the open market."}],"balance_after":0,"derivative":{"exercise_price":144.67,"exercise_date":"2020-02-22","expiration_date":"2024-02-22","underlying":"Common Stock","underlying_shares":5916},"source":{"system":"sec-edgar","filing":"0001127602-24-001215","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224001215/form4.xml","form_type":"4"}},{"id":1680955,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2024-01-11T21:09:52.000Z","date":"2024-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":4590,"price":215.19,"value":987722.1,"ownership":{"direct":true},"balance_after":45775,"source":{"system":"sec-edgar","filing":"0001127602-24-001215","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224001215/form4.xml","form_type":"4"}},{"id":1680954,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2024-01-11T21:09:52.000Z","date":"2024-01-10","kind":"exercise","planned":false,"acquired":true,"shares":5916,"price":215.19,"value":1273064.04,"ownership":{"direct":true},"balance_after":50365,"source":{"system":"sec-edgar","filing":"0001127602-24-001215","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224001215/form4.xml","form_type":"4"}},{"id":1733148,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2023-11-21T22:07:01.000Z","date":"2023-11-20","kind":"purchase","planned":false,"acquired":true,"shares":1322,"price":187.82,"value":248298.04,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The total in column 5 reflects the ownership as of the date of the transaction."}],"balance_after":44449,"source":{"system":"sec-edgar","filing":"0001127602-23-028148","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223028148/form4.xml","form_type":"4"}},{"id":1733147,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2023-11-21T22:07:01.000Z","date":"2021-03-01","kind":"gift","planned":false,"acquired":false,"shares":350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The total in column 5 reflects the ownership as of the date of the transaction."}],"balance_after":28710,"source":{"system":"sec-edgar","filing":"0001127602-23-028148","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223028148/form4.xml","form_type":"4"}},{"id":1873624,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-05-31T17:24:48.000Z","date":"2023-05-26","kind":"grant","planned":false,"acquired":true,"shares":9145,"price":194.12,"value":1775227.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Stock Options vest as follows: 2,286 on May 26, 2024, 2,286 on May 26, 2025, 2,286 on May 26, 2026 and 2,287 on May 26, 2027."}],"balance_after":9145,"derivative":{"exercise_price":194.12,"exercise_date":"2024-05-26","expiration_date":"2033-05-26","underlying":"Common Stock","underlying_shares":9145},"source":{"system":"sec-edgar","filing":"0001127602-23-017133","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223017133/form4.xml","form_type":"4"}},{"id":1873623,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2023-05-31T17:24:48.000Z","date":"2023-05-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":216,"price":194.12,"value":41929.92,"ownership":{"direct":true},"balance_after":43477,"source":{"system":"sec-edgar","filing":"0001127602-23-017133","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223017133/form4.xml","form_type":"4"}},{"id":1873622,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2023-05-31T17:24:48.000Z","date":"2023-05-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":132,"price":194.12,"value":25623.84,"ownership":{"direct":true},"balance_after":43693,"source":{"system":"sec-edgar","filing":"0001127602-23-017133","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223017133/form4.xml","form_type":"4"}},{"id":1873621,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2023-05-31T17:24:48.000Z","date":"2023-05-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":242,"price":194.12,"value":46977.04,"ownership":{"direct":true},"balance_after":43825,"source":{"system":"sec-edgar","filing":"0001127602-23-017133","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223017133/form4.xml","form_type":"4"}},{"id":1873620,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2023-05-31T17:24:48.000Z","date":"2023-05-26","kind":"grant","planned":false,"acquired":true,"shares":3812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units vest as follows: 953 on May 26, 2024, 953 on May 26, 2025, 953 on May 26, 2026 and 953 on May 26, 2027."}],"balance_after":44067,"source":{"system":"sec-edgar","filing":"0001127602-23-017133","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223017133/form4.xml","form_type":"4"}},{"id":1963867,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2023-03-08T21:16:19.000Z","date":"2023-03-07","kind":"gift","acquired":false,"shares":475,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40255,"source":{"system":"sec-edgar","filing":"0001127602-23-009447","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223009447/form4.xml","form_type":"4"}},{"id":2000511,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2023-02-22T21:19:17.000Z","date":"2023-02-22","kind":"tax_withholding","acquired":false,"shares":308,"price":243.6,"value":75028.8,"ownership":{"direct":true},"balance_after":40730,"source":{"system":"sec-edgar","filing":"0001127602-23-006456","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223006456/form4.xml","form_type":"4"}},{"id":2008430,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-02-17T22:29:07.000Z","date":"2023-02-16","kind":"exercise","acquired":false,"shares":3205,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":109.34,"exercise_date":"2019-02-23","expiration_date":"2023-02-23","underlying":"Common Stock","underlying_shares":3205},"source":{"system":"sec-edgar","filing":"0001127602-23-005905","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223005905/form4.xml","form_type":"4"}},{"id":2008429,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2023-02-17T22:29:07.000Z","date":"2023-02-16","kind":"sale","acquired":false,"shares":502,"price":256.4758,"value":128750.8516,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale occurred pursuant to a 10b5-1 Trading Plan."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $256.21 to $257.015. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":41038,"source":{"system":"sec-edgar","filing":"0001127602-23-005905","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223005905/form4.xml","form_type":"4"}},{"id":2008428,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2023-02-17T22:29:07.000Z","date":"2023-02-16","kind":"sale","acquired":false,"shares":1392,"price":255.6538,"value":355870.0896,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale occurred pursuant to a 10b5-1 Trading Plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $255.18 to $256.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":41540,"source":{"system":"sec-edgar","filing":"0001127602-23-005905","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223005905/form4.xml","form_type":"4"}},{"id":2008427,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2023-02-17T22:29:07.000Z","date":"2023-02-16","kind":"sale","acquired":false,"shares":417,"price":254.5495,"value":106147.1415,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale occurred pursuant to a 10b5-1 Trading Plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $254.08 to $254.845. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":42932,"source":{"system":"sec-edgar","filing":"0001127602-23-005905","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223005905/form4.xml","form_type":"4"}},{"id":2008426,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2023-02-17T22:29:07.000Z","date":"2023-02-16","kind":"sale","acquired":false,"shares":219,"price":253.7794,"value":55577.6886,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale occurred pursuant to a 10b5-1 Trading Plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $253.61 to $253.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":43349,"source":{"system":"sec-edgar","filing":"0001127602-23-005905","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223005905/form4.xml","form_type":"4"}},{"id":2008425,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2023-02-17T22:29:07.000Z","date":"2023-02-16","kind":"sale","acquired":false,"shares":157,"price":252.8679,"value":39700.2603,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale occurred pursuant to a 10b5-1 Trading Plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $252.84 to $252.9. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":43568,"source":{"system":"sec-edgar","filing":"0001127602-23-005905","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223005905/form4.xml","form_type":"4"}},{"id":2008424,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2023-02-17T22:29:07.000Z","date":"2023-02-16","kind":"sale","acquired":false,"shares":183,"price":251.5593,"value":46035.3519,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale occurred pursuant to a 10b5-1 Trading Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $251.42 to $252.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":43725,"source":{"system":"sec-edgar","filing":"0001127602-23-005905","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223005905/form4.xml","form_type":"4"}},{"id":2008423,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2023-02-17T22:29:07.000Z","date":"2023-02-16","kind":"sale","acquired":false,"shares":78,"price":250.69,"value":19553.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale occurred pursuant to a 10b5-1 Trading Plan."}],"balance_after":43908,"source":{"system":"sec-edgar","filing":"0001127602-23-005905","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223005905/form4.xml","form_type":"4"}},{"id":2008422,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2023-02-17T22:29:07.000Z","date":"2023-02-16","kind":"sale","acquired":false,"shares":73,"price":249.22,"value":18193.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale occurred pursuant to a 10b5-1 Trading Plan."}],"balance_after":43986,"source":{"system":"sec-edgar","filing":"0001127602-23-005905","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223005905/form4.xml","form_type":"4"}},{"id":2008421,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2023-02-17T22:29:07.000Z","date":"2023-02-16","kind":"sale","acquired":false,"shares":100,"price":248.065,"value":24806.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale occurred pursuant to a 10b5-1 Trading Plan."}],"balance_after":44059,"source":{"system":"sec-edgar","filing":"0001127602-23-005905","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223005905/form4.xml","form_type":"4"}},{"id":2008420,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2023-02-17T22:29:07.000Z","date":"2023-02-16","kind":"sale","acquired":false,"shares":84,"price":246.1293,"value":20674.8612,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale occurred pursuant to a 10b5-1 Trading Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $246.08 to $246.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":44159,"source":{"system":"sec-edgar","filing":"0001127602-23-005905","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223005905/form4.xml","form_type":"4"}},{"id":2008419,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2023-02-17T22:29:07.000Z","date":"2023-02-16","kind":"exercise","acquired":true,"shares":3205,"price":109.34,"value":350434.7,"ownership":{"direct":true},"balance_after":44243,"source":{"system":"sec-edgar","filing":"0001127602-23-005905","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223005905/form4.xml","form_type":"4"}},{"id":2042495,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2023-01-30T21:42:16.000Z","date":"2023-01-27","kind":"tax_withholding","acquired":false,"shares":3153,"price":244.29,"value":770246.37,"ownership":{"direct":true},"balance_after":41038,"source":{"system":"sec-edgar","filing":"0001127602-23-002672","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223002672/form4.xml","form_type":"4"}},{"id":2042494,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2023-01-30T21:42:16.000Z","date":"2023-01-27","kind":"grant","acquired":true,"shares":8435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 29, 2020."}],"balance_after":44191,"source":{"system":"sec-edgar","filing":"0001127602-23-002672","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223002672/form4.xml","form_type":"4"}},{"id":2251795,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-05-31T22:15:32.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":6634,"price":244.41,"value":1621415.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Stock Options vest as follows: 1,658 on May 27, 2023, 1,659 on May 27, 2024, 1,658 on May 27, 2025 and 1,659 on May 27, 2026."}],"balance_after":6634,"derivative":{"exercise_price":244.41,"exercise_date":"2023-05-27","expiration_date":"2032-05-27","underlying":"Common Stock","underlying_shares":6634},"source":{"system":"sec-edgar","filing":"0001127602-22-016064","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222016064/form4.xml","form_type":"4"}},{"id":2251794,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2022-05-31T22:15:32.000Z","date":"2022-05-29","kind":"tax_withholding","acquired":false,"shares":218,"price":244.41,"value":53281.38,"ownership":{"direct":true},"balance_after":35756,"source":{"system":"sec-edgar","filing":"0001127602-22-016064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222016064/form4.xml","form_type":"4"}},{"id":2251793,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2022-05-31T22:15:32.000Z","date":"2022-05-28","kind":"tax_withholding","acquired":false,"shares":150,"price":244.41,"value":36661.5,"ownership":{"direct":true},"balance_after":35974,"source":{"system":"sec-edgar","filing":"0001127602-22-016064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222016064/form4.xml","form_type":"4"}},{"id":2251792,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2022-05-31T22:15:32.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":2455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Unvested restricted stock units vest as follows: 613 on May 27, 2023, 614 on May 27, 2024, 614 on May 27, 2025 and 614 on May 27, 2026."}],"balance_after":36124,"source":{"system":"sec-edgar","filing":"0001127602-22-016064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222016064/form4.xml","form_type":"4"}},{"id":2379298,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2022-02-23T21:23:52.000Z","date":"2022-02-23","kind":"tax_withholding","acquired":false,"shares":280,"price":289.58,"value":81082.4,"ownership":{"direct":true},"balance_after":33669,"source":{"system":"sec-edgar","filing":"0001127602-22-006286","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222006286/form4.xml","form_type":"4"}},{"id":2379297,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2022-02-23T21:23:52.000Z","date":"2022-02-22","kind":"tax_withholding","acquired":false,"shares":274,"price":293.61,"value":80449.14,"ownership":{"direct":true},"balance_after":33949,"source":{"system":"sec-edgar","filing":"0001127602-22-006286","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222006286/form4.xml","form_type":"4"}},{"id":2419645,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2022-02-01T22:37:37.000Z","date":"2022-01-28","kind":"tax_withholding","acquired":false,"shares":3877,"price":312.24,"value":1210554.48,"ownership":{"direct":true},"balance_after":34223,"source":{"system":"sec-edgar","filing":"0001127602-22-002799","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222002799/form4.xml","form_type":"4"}},{"id":2419644,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2022-02-01T22:37:37.000Z","date":"2022-01-28","kind":"grant","acquired":true,"shares":11029,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on February 22, 2019."}],"balance_after":38100,"source":{"system":"sec-edgar","filing":"0001127602-22-002799","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222002799/form4.xml","form_type":"4"}},{"id":2419643,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP & COO"}}],"security":"Common Stock","published_at":"2022-02-01T22:37:37.000Z","date":"2021-09-23","kind":"gift","acquired":false,"shares":531,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":27071,"source":{"system":"sec-edgar","filing":"0001127602-22-002799","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222002799/form4.xml","form_type":"4"}},{"id":2569786,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Common Stock","published_at":"2021-09-15T15:11:29.000Z","date":"2021-09-14","kind":"sale","acquired":false,"shares":2344,"price":439.9,"value":1031125.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale occurred pursuant to a 10b5-1 Trading Plan."}],"balance_after":27602,"source":{"system":"sec-edgar","filing":"0001127602-21-025281","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221025281/form4.xml","form_type":"4"}},{"id":2569785,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Common Stock","published_at":"2021-09-15T15:11:29.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":7,"price":442.73,"value":3099.11,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale occurred pursuant to a 10b5-1 Trading Plan."}],"balance_after":29946,"source":{"system":"sec-edgar","filing":"0001127602-21-025281","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221025281/form4.xml","form_type":"4"}},{"id":2569784,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Common Stock","published_at":"2021-09-15T15:11:29.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":72,"price":442.15,"value":31834.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale occurred pursuant to a 10b5-1 Trading Plan."}],"balance_after":29953,"source":{"system":"sec-edgar","filing":"0001127602-21-025281","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221025281/form4.xml","form_type":"4"}},{"id":2569783,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Common Stock","published_at":"2021-09-15T15:11:29.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":2,"price":441.655,"value":883.31,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale occurred pursuant to a 10b5-1 Trading Plan."}],"balance_after":30025,"source":{"system":"sec-edgar","filing":"0001127602-21-025281","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221025281/form4.xml","form_type":"4"}},{"id":2689439,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-06-01T21:58:26.000Z","date":"2021-05-28","kind":"grant","acquired":true,"shares":3659,"price":337.99,"value":1236705.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Stock Options vest as follows: 914 on May 28, 2022, 915 on May 28, 2023, 915 on May 28, 2024 and 915 on May 28, 2025."}],"balance_after":3659,"derivative":{"exercise_price":337.99,"exercise_date":"2022-05-28","expiration_date":"2031-05-28","underlying":"Common Stock","underlying_shares":3659},"source":{"system":"sec-edgar","filing":"0001127602-21-018563","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221018563/form4.xml","form_type":"4"}},{"id":2689438,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Common Stock","published_at":"2021-06-01T21:58:26.000Z","date":"2021-05-29","kind":"tax_withholding","acquired":false,"shares":216,"price":337.99,"value":73005.84,"ownership":{"direct":true},"balance_after":30027,"source":{"system":"sec-edgar","filing":"0001127602-21-018563","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221018563/form4.xml","form_type":"4"}},{"id":2689437,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Common Stock","published_at":"2021-06-01T21:58:26.000Z","date":"2021-05-28","kind":"grant","acquired":true,"shares":1183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Unvested restricted stock units vest as follows: 295 on May 28, 2022, 296 on May 28, 2023, 296 on May 28, 2024 and 296 on May 28, 2025."}],"balance_after":30243,"source":{"system":"sec-edgar","filing":"0001127602-21-018563","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221018563/form4.xml","form_type":"4"}},{"id":2754641,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-04-07T15:26:36.000Z","date":"2021-04-06","kind":"exercise","acquired":false,"shares":5916,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5916,"derivative":{"exercise_price":144.67,"exercise_date":"2020-02-22","expiration_date":"2024-02-22","underlying":"Common Stock","underlying_shares":5916},"source":{"system":"sec-edgar","filing":"0001127602-21-013373","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221013373/form4.xml","form_type":"4"}},{"id":2754640,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-04-07T15:26:36.000Z","date":"2021-04-06","kind":"exercise","acquired":false,"shares":6409,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3205,"derivative":{"exercise_price":109.34,"exercise_date":"2019-02-23","expiration_date":"2023-02-23","underlying":"Common Stock","underlying_shares":6409},"source":{"system":"sec-edgar","filing":"0001127602-21-013373","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221013373/form4.xml","form_type":"4"}},{"id":2754639,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-04-07T15:26:36.000Z","date":"2021-04-06","kind":"exercise","acquired":false,"shares":5986,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":88.05,"exercise_date":"2018-02-24","expiration_date":"2022-02-24","underlying":"Common Stock","underlying_shares":5986},"source":{"system":"sec-edgar","filing":"0001127602-21-013373","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221013373/form4.xml","form_type":"4"}},{"id":2754638,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-04-07T15:26:36.000Z","date":"2021-04-05","kind":"exercise","acquired":false,"shares":999,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5986,"derivative":{"exercise_price":88.05,"exercise_date":"2018-02-24","expiration_date":"2022-02-24","underlying":"Common Stock","underlying_shares":999},"source":{"system":"sec-edgar","filing":"0001127602-21-013373","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221013373/form4.xml","form_type":"4"}},{"id":2754637,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Common Stock","published_at":"2021-04-07T15:26:36.000Z","date":"2021-04-06","kind":"sale","acquired":false,"shares":5916,"price":304.85,"value":1803492.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale occurred pursuant to a 10b5-1 Trading Plan."}],"balance_after":29060,"source":{"system":"sec-edgar","filing":"0001127602-21-013373","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221013373/form4.xml","form_type":"4"}},{"id":2754636,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Common Stock","published_at":"2021-04-07T15:26:36.000Z","date":"2021-04-06","kind":"exercise","acquired":true,"shares":5916,"price":144.67,"value":855867.72,"ownership":{"direct":true},"balance_after":34976,"source":{"system":"sec-edgar","filing":"0001127602-21-013373","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221013373/form4.xml","form_type":"4"}},{"id":2754635,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Common Stock","published_at":"2021-04-07T15:26:36.000Z","date":"2021-04-06","kind":"sale","acquired":false,"shares":6409,"price":304.85,"value":1953783.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale occurred pursuant to a 10b5-1 Trading Plan."}],"balance_after":29060,"source":{"system":"sec-edgar","filing":"0001127602-21-013373","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221013373/form4.xml","form_type":"4"}},{"id":2754634,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Common Stock","published_at":"2021-04-07T15:26:36.000Z","date":"2021-04-06","kind":"exercise","acquired":true,"shares":6409,"price":109.34,"value":700760.06,"ownership":{"direct":true},"balance_after":35469,"source":{"system":"sec-edgar","filing":"0001127602-21-013373","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221013373/form4.xml","form_type":"4"}},{"id":2754633,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Common Stock","published_at":"2021-04-07T15:26:36.000Z","date":"2021-04-06","kind":"sale","acquired":false,"shares":5986,"price":298,"value":1783828.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale occurred pursuant to a 10b5-1 Trading Plan."}],"balance_after":29060,"source":{"system":"sec-edgar","filing":"0001127602-21-013373","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221013373/form4.xml","form_type":"4"}},{"id":2754632,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Common Stock","published_at":"2021-04-07T15:26:36.000Z","date":"2021-04-06","kind":"exercise","acquired":true,"shares":5986,"price":88.05,"value":527067.3,"ownership":{"direct":true},"balance_after":35046,"source":{"system":"sec-edgar","filing":"0001127602-21-013373","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221013373/form4.xml","form_type":"4"}},{"id":2754631,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Common Stock","published_at":"2021-04-07T15:26:36.000Z","date":"2021-04-05","kind":"sale","acquired":false,"shares":999,"price":298,"value":297702.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale occurred pursuant to a 10b5-1 Trading Plan."}],"balance_after":29060,"source":{"system":"sec-edgar","filing":"0001127602-21-013373","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221013373/form4.xml","form_type":"4"}},{"id":2754630,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Common Stock","published_at":"2021-04-07T15:26:36.000Z","date":"2021-04-05","kind":"exercise","acquired":true,"shares":999,"price":88.05,"value":87961.95,"ownership":{"direct":true},"balance_after":30059,"source":{"system":"sec-edgar","filing":"0001127602-21-013373","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221013373/form4.xml","form_type":"4"}},{"id":2833320,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Common Stock","published_at":"2021-02-25T22:22:30.000Z","date":"2021-02-24","kind":"tax_withholding","acquired":false,"shares":322,"price":282.98,"value":91119.56,"ownership":{"direct":true},"balance_after":29060,"source":{"system":"sec-edgar","filing":"0001127602-21-007943","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221007943/form4.xml","form_type":"4"}},{"id":2840121,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-02-23T16:41:21.000Z","date":"2021-02-19","kind":"exercise","acquired":false,"shares":1675,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":73.7,"exercise_date":"2017-02-26","expiration_date":"2021-02-26","underlying":"Common Stock","underlying_shares":1675},"source":{"system":"sec-edgar","filing":"0001127602-21-007209","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221007209/form4.xml","form_type":"4"}},{"id":2840120,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Common Stock","published_at":"2021-02-23T16:41:21.000Z","date":"2021-02-23","kind":"tax_withholding","acquired":false,"shares":315,"price":283.59,"value":89330.85,"ownership":{"direct":true},"balance_after":29382,"source":{"system":"sec-edgar","filing":"0001127602-21-007209","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221007209/form4.xml","form_type":"4"}},{"id":2840119,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Common Stock","published_at":"2021-02-23T16:41:21.000Z","date":"2021-02-22","kind":"tax_withholding","acquired":false,"shares":308,"price":289.55,"value":89181.4,"ownership":{"direct":true},"balance_after":29697,"source":{"system":"sec-edgar","filing":"0001127602-21-007209","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221007209/form4.xml","form_type":"4"}},{"id":2840118,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Common Stock","published_at":"2021-02-23T16:41:21.000Z","date":"2021-02-19","kind":"sale","acquired":false,"shares":1675,"price":293.9168,"value":492310.64,"ownership":{"direct":true},"balance_after":30005,"source":{"system":"sec-edgar","filing":"0001127602-21-007209","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221007209/form4.xml","form_type":"4"}},{"id":2840117,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Common Stock","published_at":"2021-02-23T16:41:21.000Z","date":"2021-02-19","kind":"exercise","acquired":true,"shares":1675,"price":73.7,"value":123447.5,"ownership":{"direct":true},"balance_after":31680,"source":{"system":"sec-edgar","filing":"0001127602-21-007209","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221007209/form4.xml","form_type":"4"}},{"id":2886403,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Common Stock","published_at":"2021-02-02T16:17:56.000Z","date":"2021-01-29","kind":"tax_withholding","acquired":false,"shares":4709,"price":260.88,"value":1228483.92,"ownership":{"direct":true},"balance_after":30005,"source":{"system":"sec-edgar","filing":"0001127602-21-003427","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221003427/form4.xml","form_type":"4"}},{"id":2886402,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Common Stock","published_at":"2021-02-02T16:17:56.000Z","date":"2021-01-29","kind":"grant","acquired":true,"shares":11862,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on February 23, 2018."}],"balance_after":34714,"source":{"system":"sec-edgar","filing":"0001127602-21-003427","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221003427/form4.xml","form_type":"4"}},{"id":3050126,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Common Stock","published_at":"2020-08-21T14:48:24.000Z","date":"2020-08-20","kind":"sale","acquired":false,"shares":933,"price":213.51,"value":199204.83,"ownership":{"direct":true},"balance_after":22852,"source":{"system":"sec-edgar","filing":"0001127602-20-024018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220024018/form4.xml","form_type":"4"}}],"next_cursor":"2020-08-21T14:48:24.000000Z,3050126"}